Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating ACLF

NCT06884904 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Acute-On-Chronic Liver Failure

Interventions

DRUG: Low-dose experimental group
DRUG: High-dose experimental group
DRUG: Low-dose placebo control group
DRUG: High-dose placebo control group

Sponsor

National Engineering Center of Cell Products